Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2021-11-25 2021-11-24
Drug Identification Number 02243237 02243237
Brand name RAPAMUNE RAPAMUNE
Common or Proper name RAPAMUNE RAPAMUNE
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients SIROLIMUS SIROLIMUS
Strength(s) 1.0MG 1.0MG
Dosage form(s) SOLUTION SOLUTION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60ML 60ML
ATC code L04AA L04AA
ATC description IMMUNOSUPPRESSANTS IMMUNOSUPPRESSANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-24 2021-11-24
Estimated end date 2022-03-15 2022-03-15
Actual end date
Shortage status Actual shortage Anticipated shortage
Company comments On preventive allocation Our other presentation 1mg Tablet remain available On preventive allocation Our other presentation 1mg Tablet remain available
Health Canada comments